Avant Diagnostics, Inc. (OTCQB: AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company is seeking FDA approval of a test for early detection for pre-symptomatic ovarian cancer.

Biotechnology

Avant Diagnostics

Avant Diagnostics' headquarters in Golden, CO, United States

Mick Ruxin

Mike Vallone

Claudius Mueller

Mattia Cremona

Trevor McCartney

Lance Liotta

Emanuel F. Petricoin

Virginia Espina

Jeffrey Busch

Yvonne C. Fors

Andrew Al Kucharchuk

Matthew Schwartz

Danica C. Holley

This department is responsible for strategic direction and decision-making within the organization.

Leadership Council

The Advisory Board at Avant Diagnostics provides strategic guidance and expert insight to support the company's mission of advancing medical diagnostic technology. Comprised of medical and scientific experts, the board focuses on enhancing the development and FDA approval process of Avant's early detection test for pre-symptomatic ovarian cancer.

Advisory Board

The Leadership Team at Avant Diagnostics is responsible for setting the strategic direction of the company, overseeing the development and implementation of innovative diagnostic technologies, and driving initiatives for FDA approval of new tests. They collaborate closely to foster partnerships, enhance sales operations, and ensure the company meets its goals in advancing medical diagnostics, particularly in the early detection of ovarian cancer.

Avant Diagnostics

Org chart

Board & advisors

Teams

Leadership Council

Advisory Board

Leadership Team

Offices

Avant Diagnostics

Org chart

Board & advisors

Teams

Leadership Council

Advisory Board

Leadership Team

Offices

Related companies